257 related articles for article (PubMed ID: 19939939)
1. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G
J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939
[TBL] [Abstract][Full Text] [Related]
2. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
3. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
[TBL] [Abstract][Full Text] [Related]
4. Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.
Li A; Tian X; Zhang X; Huang S; Ma Y; Wu D; Moeckel G; Somlo S; Wu G
Am J Pathol; 2015 Oct; 185(10):2843-60. PubMed ID: 26435415
[TBL] [Abstract][Full Text] [Related]
5. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
6. Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.
Li A; Xu Y; Fan S; Meng J; Shen X; Xiao Q; Li Y; Zhang L; Zhang X; Wu G; Liang C; Wu D
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515026
[TBL] [Abstract][Full Text] [Related]
7. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
8. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
[TBL] [Abstract][Full Text] [Related]
11. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
[TBL] [Abstract][Full Text] [Related]
12. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
[TBL] [Abstract][Full Text] [Related]
13. Cyst formation following disruption of intracellular calcium signaling.
Kuo IY; DesRochers TM; Kimmerling EP; Nguyen L; Ehrlich BE; Kaplan DL
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14283-8. PubMed ID: 25228769
[TBL] [Abstract][Full Text] [Related]
14. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.
Doctor RB; Serkova NJ; Hasebroock KM; Zafar I; Edelstein CL
Nephrol Dial Transplant; 2010 Nov; 25(11):3496-504. PubMed ID: 20388629
[TBL] [Abstract][Full Text] [Related]
16. Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress.
Giehl E; Lemos FO; Huang Y; Giordano FJ; Kuo IY; Ehrlich BE
Pflugers Arch; 2017 Nov; 469(11):1507-1517. PubMed ID: 28762163
[TBL] [Abstract][Full Text] [Related]
17. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
18. T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease.
Miller MM; Iglesias DM; Zhang Z; Corsini R; Chu L; Murawski I; Gupta I; Somlo S; Germino GG; Goodyer PR
Kidney Int; 2011 Jul; 80(2):146-53. PubMed ID: 21389971
[TBL] [Abstract][Full Text] [Related]
19. Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD).
Peintner L; Borner C
Cell Tissue Res; 2017 Jul; 369(1):27-39. PubMed ID: 28560694
[TBL] [Abstract][Full Text] [Related]
20. IFT-A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease.
Wang W; Pottorf TS; Wang HH; Dong R; Kavanaugh MA; Cornelius JT; Dennis KL; Apte U; Pritchard MT; Sharma M; Tran PV
J Pathol; 2021 Jul; 254(3):289-302. PubMed ID: 33900625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]